Cancer Stem Cell Markers and Related Network Pathways - Shihori Tanabe
- Format: Relié
- 172 pages Voir le descriptif
Vous en avez un à vendre ?
Vendez-le-vôtre98,99 €
Produit Neuf
Ou 24,75 € /mois
- Livraison à 0,01 €
- Livré entre le 8 et le 15 octobre
Pro Seller. Delivery average : 16 days in North America, 21 days in South America, 16 days in Europe, 21 days in Asia/Oceania
Détails de conformité du produit
Personne responsable dans l'UE
- Payez directement sur Rakuten (CB, PayPal, 4xCB...)
- Récupérez le produit directement chez le vendeur
- Rakuten vous rembourse en cas de problème
Gratuit et sans engagement
Félicitations !
Nous sommes heureux de vous compter parmi nos membres du Club Rakuten !
TROUVER UN MAGASIN
Retour
Avis sur Cancer Stem Cell Markers And Related Network Pathways de Shihori Tanabe Format Relié - Livre
0 avis sur Cancer Stem Cell Markers And Related Network Pathways de Shihori Tanabe Format Relié - Livre
Donnez votre avis et cumulez 5
Les avis publiés font l'objet d'un contrôle automatisé de Rakuten.
Présentation Cancer Stem Cell Markers And Related Network Pathways de Shihori Tanabe Format Relié
- Livre- Auteur(s) : Shihori Tanabe
- Editeur : Springer International Publishing
- Langue : Anglais
- Parution : 01/01/2023
- Nombre de pages : 172
- Expédition : 572
- Dimensions : 26.0 x 18.3 x 1.5
Résumé :
Biographie:
Shihori Tanabe, Ph.D. has been working as a Senior Researcher at the Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences from April 2016. From Apr 2005 until Jan 2006 she held a position of a Post Doctoral Fellow at the Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, The University of Tokyo. From Feb 2006 until Mar 2010 she worked as a Researcher at the Division of Cellular and Gene Therapy Products, National Institute of Health Sciences, Tokyo Japan. She also had a position of a Senior Researcher at the Division of Safety Information on Drug, Food and Chemicals, National Institute of Health Sciences (Apr 2010 - Mar 2016, Tokyo Japan)
Sommaire:
1. Epithelial-mesenchymal transition and cancer stem cells.- 2. The transcription factors Zeb1 and Snail induce cell malignancy and can-cer stem cell phenotype in prostate cells, increasing androgen synthesis ca-pacity and therapy resistance.- 3. ERBB signaling pathway in cancer stem cells.- 4. Functional and molecular characters of cancer stem cells through devel-opment to establishment.- 5. Microenvironment in cancer stem cells.- 6. Cancer stem cells contribute to drug resistance in multiple different ways.- 7. Abnormal glycosylation in cancer cells and cancer stem cells as a thera-peutic target.